Oscar Health, Inc. (OSCR)

$16.83

+0.55

(+3.38%)▲

Market is closed - opens 8 PM, 29 Nov 2024

Oscar Health, Inc. Key Statistics

Market Capitalization
$4.0B
Revenue TTM
$8.2B
EBITDA
$43.9M
Earnings Per Share (EPS)
$-0.02
Profit Margin
0.35%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
2.83%

Oscar Health, Inc. share price movements

  • $16.50
    $17.06
    $16.83
    downward going graph

    1.96%

    Downside

    Day's Volatility :3.25%

    Upside

    1.32%

    downward going graph
  • $7.29
    $23.79
    $16.83
    downward going graph

    56.68%

    Downside

    52 Weeks Volatility :69.36%

    Upside

    29.26%

    downward going graph

Oscar Health, Inc. Returns

PeriodOscar Health, Inc.Sector (Financials)Index (Russel 2000)
3 Months
-5.5%
13.1%
0.0%
6 Months
-16.6%
25.6%
0.0%
1 Year
98.94%
44.4%
0.0%
3 Years
81.55%
31.8%
-21.1%

Analyst Recommendation on Oscar Health, Inc.

Buy
    72%Buy
    27%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for Oscar Health, Inc.(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
7
Hold
3
3
4
Sell
00
00
00

Analyst Forecast on Oscar Health, Inc.

What analysts predicted

Upside of 22.3%

Current $16.83
Target $20.58

Insights on Oscar Health, Inc.

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 1.43B → 2.42B (in $), with an average increase of 15.0% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 177.36M → -54.59M (in $), with an average decrease of 132.7% per quarter

Oscar Health, Inc. Financials in INR & Dollars

FY19Y/Y Change
Revenue
553.8M
-
Net Income
-261.2M
-
Net Profit Margin
-47.16%
-
FY20Y/Y Change
Revenue
589.6M
↑ 6.48%
Net Income
-406.8M
↑ 55.76%
Net Profit Margin
-69.0%
↓ 21.84%
FY21Y/Y Change
Revenue
1.9B
↑ 225.78%
Net Income
-571.4M
↑ 40.46%
Net Profit Margin
-29.75%
↑ 39.25%
FY22Y/Y Change
Revenue
4.1B
↑ 114.77%
Net Income
-609.6M
↑ 6.67%
Net Profit Margin
-14.77%
↑ 14.98%
FY23Y/Y Change
Revenue
5.9B
↑ 42.11%
Net Income
-270.7M
↓ 55.59%
Net Profit Margin
-4.62%
↑ 10.15%
Q2 FY23Q/Q Change
Revenue
1.5B
↑ 3.68%
Net Income
-15.5M
↓ 60.82%
Net Profit Margin
-1.02%
↑ 1.68%
Q3 FY23Q/Q Change
Revenue
1.4B
↓ 5.4%
Net Income
-65.4M
↑ 321.16%
Net Profit Margin
-4.54%
↓ 3.52%
Q4 FY23Q/Q Change
Revenue
1.4B
↓ 0.58%
Net Income
-150.0M
↑ 129.41%
Net Profit Margin
-10.48%
↓ 5.94%
Q1 FY24Q/Q Change
Revenue
2.1B
↑ 49.64%
Net Income
177.4M
↓ 218.22%
Net Profit Margin
8.28%
↑ 18.76%
Q2 FY24Q/Q Change
Revenue
2.2B
↑ 3.6%
Net Income
56.2M
↓ 68.31%
Net Profit Margin
2.53%
↓ 5.75%
Q3 FY24Q/Q Change
Revenue
2.4B
↑ 9.2%
Net Income
-54.6M
↓ 197.13%
Net Profit Margin
-2.25%
↓ 4.78%
FY19Y/Y Change
Total Assets
1.3B
-
Total Liabilities
494.2M
-
FY20Y/Y Change
Total Assets
2.3B
↑ 68.69%
Total Liabilities
3.6B
↑ 621.92%
FY21Y/Y Change
Total Assets
3.3B
↑ 46.19%
Total Liabilities
440.0M
↓ 87.67%
FY22Y/Y Change
Total Assets
4.5B
↑ 36.28%
Total Liabilities
3.6B
↑ 725.92%
FY23Y/Y Change
Total Assets
3.6B
↓ 20.44%
Total Liabilities
2.8B
↓ 23.08%
Q2 FY23Q/Q Change
Total Assets
4.6B
↑ 1.83%
Total Liabilities
3.6B
↑ 1.74%
Q3 FY23Q/Q Change
Total Assets
3.3B
↓ 26.63%
Total Liabilities
2.4B
↓ 32.8%
Q4 FY23Q/Q Change
Total Assets
3.4B
↑ 0.32%
Total Liabilities
2.6B
↑ 5.19%
Q1 FY24Q/Q Change
Total Assets
4.2B
↑ 24.27%
Total Liabilities
3.1B
↑ 23.0%
Q2 FY24Q/Q Change
Total Assets
4.8B
↑ 14.1%
Total Liabilities
3.6B
↑ 15.36%
Q3 FY24Q/Q Change
Total Assets
4.5B
↓ 5.92%
Total Liabilities
3.3B
↓ 8.46%
FY19Y/Y Change
Operating Cash Flow
-165.4M
-
Investing Cash Flow
150.5M
-
Financing Cash Flow
-2.1M
-
FY20Y/Y Change
Operating Cash Flow
222.7M
↓ 234.69%
Investing Cash Flow
-344.7M
↓ 329.03%
Financing Cash Flow
611.7M
↓ 28967.72%
FY21Y/Y Change
Operating Cash Flow
-181.7M
↓ 181.6%
Investing Cash Flow
-774.5M
↑ 124.68%
Financing Cash Flow
1.2B
↑ 102.5%
FY22Y/Y Change
Operating Cash Flow
380.3M
↓ 309.28%
Investing Cash Flow
-226.5M
↓ 70.75%
Financing Cash Flow
301.1M
↓ 75.69%
Q2 FY23Q/Q Change
Operating Cash Flow
165.5M
↓ 60.09%
Investing Cash Flow
43.9M
↓ 67.61%
Financing Cash Flow
2.6M
↑ 404.15%
Q3 FY23Q/Q Change
Operating Cash Flow
-1.1B
↓ 794.32%
Investing Cash Flow
225.3M
↑ 413.24%
Financing Cash Flow
2.3M
↓ 9.06%

Oscar Health, Inc. Technicals Summary

Sell

Neutral

Buy

Oscar Health, Inc. is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Oscar Health, Inc. Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Oscar Health, Inc.
Oscar Health, Inc.
5.65%
-16.6%
98.94%
81.55%
-51.64%
The Cigna Corp
The Cigna Corp
9.17%
1.08%
28.01%
68.58%
68.32%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
8.23%
25.51%
13.72%
34.6%
117.38%
Cvs Health Corporation
Cvs Health Corporation
6.6%
11.72%
-10.37%
-34.84%
-20.34%
Humana Inc.
Humana Inc.
15.09%
-14.08%
-38.5%
-30.69%
-13.06%
Elevance Health, Inc
Elevance Health, Inc
-1.9%
-20.33%
-13.45%
-3.24%
39.52%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Oscar Health, Inc.
Oscar Health, Inc.
NA
NA
NA
0.09
0.03
0.0
NA
4.71
The Cigna Corp
The Cigna Corp
31.75
31.75
0.8
28.5
0.08
0.03
0.02
150.61
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
39.53
39.53
1.65
27.61
0.15
0.07
0.01
102.42
Cvs Health Corporation
Cvs Health Corporation
14.95
14.95
2.23
5.34
0.07
0.02
0.05
59.57
Humana Inc.
Humana Inc.
25.78
25.78
1.35
16.14
0.08
0.04
0.01
145.88
Elevance Health, Inc
Elevance Health, Inc
14.66
14.66
0.75
33.04
0.16
0.06
0.02
188.74
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Oscar Health, Inc.
Oscar Health, Inc.
Buy
$4.0B
-51.64%
NA
0.35%
The Cigna Corp
The Cigna Corp
Buy
$93.6B
68.32%
31.75
1.32%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
Buy
$559.9B
117.38%
39.53
3.64%
Cvs Health Corporation
Cvs Health Corporation
Buy
$75.5B
-20.34%
14.95
1.37%
Humana Inc.
Humana Inc.
Buy
$35.7B
-13.06%
25.78
1.18%
Elevance Health, Inc
Elevance Health, Inc
Buy
$93.4B
39.52%
14.66
3.69%

Oscar Health, Inc. Institutional Holdings

  • Vanguard Group Inc

    7.45%

  • BlackRock Inc

    5.73%

  • T. Rowe Price Investment Management,Inc.

    4.72%

  • Dragoneer Investment Group, LLC

    3.84%

  • Deerfield Management Co

    3.18%

  • Viking Global Investors LP

    2.50%

Corporate Announcements

  • Oscar Health, Inc. Earnings

    Oscar Health, Inc.’s price-to-earnings ratio stands at None

    Read More

About Oscar Health, Inc.

healthcare is broken; we're trying to fix it. the oscar team is focused on utilizing technology, design and data to humanize healthcare. we're a group of technology and healthcare professionals who looked at the current state of the us healthcare system, got frustrated by the horrible consumer experience, and decided to do something big about it. backed by a renowned set of investors and advisors, we’ve set out to revolutionize healthcare.

Organization
Oscar Health, Inc.
Employees
2400
CEO
Mr. Mark Thomas Bertolini
Industry
Financial

FAQs